DC
Dennis J Phd Carlo

Dennis J Phd Carlo insider trades: Adamis Pharmaceuticals (ADMP) stock sales

Adamis Pharmaceuticals Last trade Mar 18, 2022 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2019
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Dennis reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 18, 2022ADMP↓ Sell10b5-1$6K
Dec 1, 2021ADMP↓ Sell$38K
Nov 18, 2020ADMP↓ Sell$4K
Aug 18, 2020ADMP↓ Sell$10K
May 18, 2020ADMP↓ Sell$6K
Mar 18, 2020ADMP↓ Sell$4K
Feb 24, 2020ADMP↓ Sell$8K
Nov 18, 2019ADMP↓ Sell$9K
Aug 19, 2019ADMP↓ Sell$11K
May 20, 2019ADMP↓ Sell$19K
Mar 20, 2019ADMP↓ Sell$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Dennis J Phd Carlo's insider trades

Dennis J Phd Carlo is an insider at Adamis Pharmaceuticals (ADMP). Since Mar 20, 2019, Dennis has reported no open-market purchases and 11 sales worth $144K on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (4% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (9 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.